Income Taxes (Details) - Schedule of consolidated statements of income and comprehensive income of reconciliation for income taxes - USD ($) |
6 Months Ended | ||
|---|---|---|---|
Apr. 01, 2019 |
Mar. 31, 2022 |
Mar. 31, 2021 |
|
| Schedule Of Consolidated Statements Of Income And Comprehensive Income Of Reconciliation For Income Taxes Abstract | |||
| Income before taxes | $ (9,150) | $ 711,957 | |
| PRC EIT tax rates | 13.00% | 15.00% | 15.00% |
| Tax at the PRC EIT tax rates | $ 106,793 | ||
| Tax effect of R&D expenses deduction | (104,465) | ||
| Tax effect of non-taxable investment income and government grant | (2,328) | ||
| Tax effect of deferred tax recognized | 69,626 | ||
| Income tax expenses (benefits) | $ 69,626 | ||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Tax at the PRC EIT tax rates. No definition available.
|
| X | ||||||||||
- Definition Tax effect of deferred tax recognized. No definition available.
|
| X | ||||||||||
- Definition Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of tax (expense) benefit from continuing operations attributable to government grants to the extent recognized as a reduction of income tax expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|